<DOC>
	<DOC>NCT03065530</DOC>
	<brief_summary>Nervous, anxiety, fear and other psychological reactions always appears in parturients during cesarean section. This study intends to investigate the effectiveness and safety of dexmedetomidine combined with butorphanol tartrate for postoperative analgesia and breastfeeding after caesarean section.</brief_summary>
	<brief_title>Intravenous Dexmedetomidine for Cesarean Section</brief_title>
	<detailed_description />
	<mesh_term>Pain, Postoperative</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<mesh_term>Butorphanol</mesh_term>
	<criteria>1. Parturients undergoing elective caesarean delivery under epidural anaesthesia 2. ASA I and II parturients aged 1842 years, with singleton gestation. 3. Parturients with verbal and written mandarin 4. Parturients who want to use PCA intravenous analgesia and can use the pump correctly 5. written informed consent. Exclusion Criteria 1. Multiple gestation. 2. A history of allergy to dexmedetomidine or other study drugs 3. Cardiovascular disease (basic HR&lt;50bpm or SBP&lt;100mmHg) 4. Opioid drugs abuse. 5. BMI more than 35 kg/m2 6. Conditions that preclude spinal anesthesia. 7. Preeclampsia or epilepsy. 8. A history of neuromuscular disease. 9. Epidural anaesthesia was unsuccessful.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>42 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Dexmedetomidine</keyword>
	<keyword>Butorphanol tartrate</keyword>
	<keyword>Analgesia</keyword>
	<keyword>Breastfeeding</keyword>
	<keyword>Relative infant dose</keyword>
</DOC>